Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Current immunosuppressive therapy carries a range of unwanted side effects, and tends to penalize the whole immune system. It is desirable to develop therapies that are more selective for antigen-reactive cells. As T lymphocytes use a wide range of surface receptors to interact with antigen-bearing cells and with each other, much interest is devoted to trying to develop agents that selectively block the interaction of these receptors with their ligands, and others that could be used to reprogram the immune system so that it might become tolerant to the antigens rather than attack them.

Type

Journal article

Journal

Curr Opin Biotechnol

Publication Date

12/1992

Volume

3

Pages

668 - 674

Keywords

Animals, Antibodies, Monoclonal, Humans, Immunosuppression, Immunotherapy, Models, Biological, Receptors, Leukocyte-Adhesion, T-Lymphocytes